Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2005
03/09/2005EP1289512B1 Agents and methods for increasing brain chaperonin levels
03/09/2005EP1255552B1 Prostaglandin compositions for the treatment for male erectile dysfunction
03/09/2005EP1162959B1 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
03/09/2005EP1137429B1 Cherry extracts for inhibiting cyclooxygenase enzymes
03/09/2005EP1108026B1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
03/09/2005EP1018008B1 Method of identification of leads or active compounds
03/09/2005EP0991425B1 Pro
03/09/2005EP0944645B1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME
03/09/2005EP0935471B1 Mononuclear phagocytes in therapeutic drug delivery
03/09/2005EP0839149B9 Galanthamine derivatives, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing such derivatives
03/09/2005EP0817627B1 Protein kinase c inhibitors
03/09/2005EP0779076B1 Peptide, a method of obtaining it and a pharmaceutical compound based on it
03/09/2005EP0756005B1 Gene coding for adseverin
03/09/2005CN1592752A Inhibitors of the E2F-1/cyclin interaction for cancer therapy
03/09/2005CN1592748A Separation of regioisomers of metal phthalocyanines
03/09/2005CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity
03/09/2005CN1592744A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
03/09/2005CN1592743A Inhibitors of glycogen synthase kinase 3
03/09/2005CN1592742A Neurotensin active 2, 3-diaryl-pyrazolidine derivatives
03/09/2005CN1592739A Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders
03/09/2005CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination
03/09/2005CN1592638A Promoters exhibiting endothelial cell specificity and methods of using same
03/09/2005CN1592637A Medicinal compositions
03/09/2005CN1592635A Autologous growth factor cocktail composition, method of production and use
03/09/2005CN1592633A T-cell epitodes in carboxypeptidase G2
03/09/2005CN1592630A Injection solution comprising an LHRH antagonist
03/09/2005CN1592627A Carbon dioxide compositions for external use and process for producing the same
03/09/2005CN1592626A Homeostasis-maintaining agents
03/09/2005CN1592624A Substituted-triazolopyrimidines as anticancer agents
03/09/2005CN1592623A Acetylene derivatives having human matabotropic glutamate receptor antagonistic activity
03/09/2005CN1592622A Orodispersible tablets containing fexofenadine
03/09/2005CN1592621A Zolpidem hemitartrate
03/09/2005CN1592620A Treating and preventing method of disease relative to cardiac insulin resistance
03/09/2005CN1592619A Pyranoindazoles and their use for the treatment of glaucoma
03/09/2005CN1592616A GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity
03/09/2005CN1592615A Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
03/09/2005CN1592614A Partial dopamine-d 2 receptor agonist plus serotonin and/oder noradrenaline inhibitor activity
03/09/2005CN1592576A Disruption of the prostaglandin E synthase 2 gene
03/09/2005CN1590375A TNF-alpha prodn. inhibitors
03/09/2005CN1590374A TNF-alpha prodn. inhibitors
03/09/2005CN1590373A Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol
03/09/2005CN1589906A New oral formulation for 5-HT4 agonists or antagonists
03/09/2005CN1589855A Application of red sage root and its prepatation in making medicine for treating aspirin resistance blood vessel disease
03/09/2005CN1589846A Force strengening plaster
03/09/2005CN1589844A Cerebrum nurishment intensification prescription
03/09/2005CN1589778A Microencapsulated saccharomyces and its application
03/09/2005CN1589777A Microencapsulated saccharomyces and its application
03/09/2005CN1589776A Microencapsulated saccharomyces and its application
03/09/2005CN1192105C A variant of C6 beta-chemokine leukotactin-1(shLKn-1) with enhanced biological activity
03/09/2005CN1192102C Enzyme catalyzed therapeutic agents
03/09/2005CN1192098C Bio-active substance of antrodia camphorata mycelia, its preparing process and its composition
03/09/2005CN1192035C Inhibitors of interleukin-1'beta' converting enzyme
03/09/2005CN1192032C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
03/09/2005CN1192031C Epothilones derivatives, their synthesis and uses
03/09/2005CN1192025C Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
03/09/2005CN1192020C Antidiabetic agents
03/09/2005CN1192016C Process for preparation of 4-(des-dimethylamino)-tetracyclines
03/09/2005CN1192015C Cell adhesion inhibitors
03/09/2005CN1192011C Calcium receptor-active arylalkyl amines
03/09/2005CN1191872C Device for delivery of macromolecules into cells
03/09/2005CN1191863C Formulations for protection of PEG-alpha interferon conjugates
03/09/2005CN1191858C Method for inhibiting brain tnmor growth
03/09/2005CN1191857C potentiation of anti-CD38-immunotoxin cytotoxicity
03/08/2005US6864383 Ophthalmic compositions for treating ocular hypertension
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864379 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
03/08/2005US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
03/08/2005US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
03/08/2005US6864290 Statine derivatives for the treatment of Alzheimer's disease
03/08/2005US6864288 Regulation of phospholipase D activity
03/08/2005US6864285 Hypotensive agents; antihistamines; immunology moderators; antiinflammatory agents
03/08/2005US6864284 Ascorbic acid compounds, methods of synthesis and application use thereof
03/08/2005US6864283 Marine extracts; analogs of the spisulosine family
03/08/2005US6864282 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
03/08/2005US6864266 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
03/08/2005US6864265 Chemokine receptor binding heterocyclic compounds
03/08/2005US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
03/08/2005US6864260 Inhibit p38- alpha kinase using compounds of the formula and the pharmaceutically acceptable salts thereof, or a pharmaceutical composition thereof, wherein noninterfering substituent;
03/08/2005US6864259 Antibacterial agents
03/08/2005US6864253 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders
03/08/2005US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer
03/08/2005US6864250 N-acylated lipophilic amino acid derivatives
03/08/2005US6864249 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants.
03/08/2005US6864246 Anticholesterol agents
03/08/2005US6864243 Method for treating retinal degeneration with purinergic receptor agonists
03/08/2005US6864229 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
03/08/2005US6864070 Polypeptide for use in the treatment of vision defects and psychological disorders
03/08/2005US6864054 Polypeptides from CREB binding protein and related protein p300 for use in transcriptional regulation
03/08/2005US6863902 Mixture of methyl hydrogen 9,11 alpha-epoxy-17 alpha-hydroxy-3-oxopregn-4-ene-7-alpha, 21-dicarboxylate, gamma-lactone and carriers administered as aldosterone receptor antagonists, for prophylaxis of cardiovascular disorders
03/08/2005US6863647 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
03/08/2005CA2351848C Method for increasing pet activity
03/03/2005WO2005019465A1 Sugar chain-cutting agent
03/03/2005WO2005019245A1 Heptadepsin
03/03/2005WO2005019244A1 Peptides which can bind to transforming growth factor beta 1 (tgf-beta1)
03/03/2005WO2005019225A1 Process for producing compound having nk1 receptor antagonism and production intermediate thereof
03/03/2005WO2005019219A1 Pyrrolopyrimidinone derivative
03/03/2005WO2005019218A1 Pyrrolopyrimidinethione derivative
03/03/2005WO2005019188A1 Fused pyrimidine derivative and use thereof
03/03/2005WO2005018674A1 Remedy for diseases associated with immunoglobulin gene translocation
03/03/2005WO2005018649A1 Agent for inhibiting the formation of final saccharification product
1 ... 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 ... 1564